Richard Malabre
Comptroller/Controller/Auditor at AKEBIA THERAPEUTICS, INC.
Net worth: 297 854 $ as of 29/04/2024
Profile
Richard C.
Malabre is currently the Chief Accounting Officer at Akebia Therapeutics, Inc. Prior to this, he was the Chief Financial Officer & Treasurer at Ultivue, Inc. from 2021 to 2023.
Malabre has a graduate degree from the Massachusetts Institute of Technology and an undergraduate degree from Trinity College (Connecticut).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/01/2024 | 223,950 ( 0.11% ) | 297 854 $ | 29/04/2024 |
Richard Malabre active positions
| Companies | Position | Start |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 07/01/2024 |
Former positions of Richard Malabre
| Companies | Position | End |
|---|---|---|
Ultivue, Inc.
 Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Director of Finance/CFO | 31/08/2023 |
Training of Richard Malabre
| Massachusetts Institute of Technology | Graduate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ultivue, Inc.
Ultivue, Inc. BiotechnologyHealth Technology Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Richard Malabre
